ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 48 filers reported holding ACUMEN PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,864,345 | +35.5% | 1,895,023 | +57.1% | 0.05% | +50.0% |
| Q2 2023 | $5,803,496 | +18.5% | 1,206,548 | 0.0% | 0.03% | -3.0% |
| Q1 2023 | $4,898,585 | -24.8% | 1,206,548 | 0.0% | 0.03% | +10.0% |
| Q4 2022 | $6,515,359 | -46.2% | 1,206,548 | 0.0% | 0.03% | -57.7% |
| Q3 2022 | $12,101,000 | +113.4% | 1,206,548 | 0.0% | 0.07% | -19.3% |
| Q2 2022 | $5,671,000 | +120.8% | 1,206,548 | +83.7% | 0.09% | +183.9% |
| Q1 2022 | $2,568,000 | -42.2% | 656,848 | 0.0% | 0.03% | -31.1% |
| Q4 2021 | $4,440,000 | -54.5% | 656,848 | 0.0% | 0.04% | +9.8% |
| Q3 2021 | $9,761,000 | – | 656,848 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 3,417,075 | $14,180,861 | 4.20% |
| Knollwood Investment Advisory, LLC | 1,628,510 | $6,758,317 | 3.16% |
| Altium Capital Management LP | 650,000 | $2,697,500 | 1.41% |
| RA Capital Management | 14,932,063 | $61,968,061 | 1.22% |
| GREAT POINT PARTNERS LLC | 1,074,101 | $4,457,519 | 0.81% |
| Boxer Capital, LLC | 2,206,983 | $9,158,979 | 0.49% |
| Deep Track Capital, LP | 2,513,044 | $10,429,133 | 0.40% |
| Parkman Healthcare Partners LLC | 499,814 | $2,074,228 | 0.38% |
| Rock Springs Capital Management LP | 2,812,579 | $11,672,203 | 0.31% |
| Ghost Tree Capital, LLC | 150,000 | $622,500 | 0.20% |